Biotech ETFs can Cope With the new White House
January 24, 2017 at 11:45 AM EST
The healthcare sector was a laggard last year, but the iShares Nasdaq Biotechnology ETF (NasdaqGM: IBB), SPDR S&P Biotech ETF (NYSEArca: XBI) and other biotechnology exchange traded funds are shaking out of that slumber with some solid gains in 2017’s early stages. Healthcare stocks and ETFs rallied immediately following Republican Donald Trump’s surprising November victory.…